The report found that, for the first time in 16 years, oncology has been surpassed as the largest contributor to late-stage pipeline value by obesity treatments
Los nuevos medicamentos, como los agonistas del GLP-1 , Semaglutida y Tirzepatida, no solo facilitan una reduccin significativa del peso mediante la imitacin de las hormonas naturales de la saciedad sino que tambin contribuyen a mejorar los perfiles metablicos y a mantener los resultados a largo plazo
Weight Loss : Semaglutide leads to more significant weight loss, often 15-20% of body weight, while berberine promotes modest but steady fat loss, around 5-10 pounds over time
If a product produces no measurable weight change, the cost-per-kilo-lost is effectively infinite
You can resume normal activity from there
Berberine supports metabolism via the AMPK pathway, helping with blood sugar and weight control